Faculty Honored at 52nd Annual Radiation Oncology Research Seminar

The University of Florida College of Medicine Department of Radiation Oncology conducted its 52nd annual Research Seminar February 18-19, 2022 at the Best Western Gateway Grand, Gainesville, Florida.

Lori Rice, PhDFor over 50 years, the seminar’s data-driven research has served as a foundation for innovation within the department and has improved outcomes for radiotherapy patients worldwide. The event allows the UF team to keep pace with current technologies and approaches and helps lead new generations of radiation oncologists into the future of cancer research and treatment.

Bo Lu, PhD

The seminar concluded with an annual awards ceremony on Saturday morning, February 19. Lori Rice, PhD (shown above, right)was the recipient of the Basic Research Education Award, which recognizes any research faculty member who provides outstanding educational opportunities to graduate and/or postdoctoral students.

Jiyeon Park, PhD

The Medical Physics Clinical Award, which recognizes medical physicists who exemplify patient-centered delivery of cancer care through their interactions with the radiation oncology team, was given to Bo Lu, PhD (Gainesville, shown above, left) and Jiyeon Park, PhD (Jacksonville, shown right).

Daniel Indelicato, MD

Finally, Daniel Indelicato, MD (shown left), was recognized with the Transformative Medicine Award, which honors translational science investigators and clinicians epitomizing innovative and collaborative efforts to accelerate the transition of scientific discoveries into new cancer therapies. The award seeks to recognize translational researchers (team or individual) leading to improved therapies, new discoveries, and significant contributions to the body of knowledge regarding radiation oncology.

The 2022 Keynote Speaker was Shannon MacDonald, MD, Associate Professor, Harvard Medical School. Dr. MacDonald serves as Director of the Base-of-Skull Service and a member of the Pediatric Service in the Department of Radiation Oncology at the Massachusetts General Hospital. Previously, she also served as a member of the Breast Service from 2006 to 2018 and Director of the Breast Service. Her expertise lies in the treatment of breast, pediatric, and base-of-skull tumors.


U.S. News and World Report

Nationally ranked in 6 adult specialties and 6 pediatric specialties and rated high performing in 4 adult specialties and 5 procedures and conditions.